Gamida Cell Ltd. Gains 38.79%

Gamida Cell Ltd. (GMDA:NASDAQ) jumped higher at $1.12, representing a gain of 38.8%. On Mon, Apr 17, 2023, GMDA:NASDAQ hit a New 2-Week High of $1.12. The stock got featured on our News Catalysts scanner on Mon, Apr 17, 2023 at 05:03 PM in the 'BIOTECH' category. From Mon, Apr 03, 2023, the stock recorded 33.33% Up Days and 30.00% Green Days

About Gamida Cell Ltd. (GMDA:NASDAQ)

Gamida Cell Ltd is engaged in the development of cellular and immune therapeutics for cancer and rare genetic diseases. The company's lead product candidate is NiCord, a nicotinamide (NAM)-expanded cord blood cell therapy for use as a curative stem cell graft for patients in hematopoietic stem cell transplant. It is also developing NAM-NK, an innate immunotherapy of expanded natural killer cells, for the treatment of refractory non-Hodgkin lymphoma and multiple myeloma.